These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 7707115)

  • 21. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
    Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
    Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors.
    Garaventa A; Boni L; Lo Piccolo MS; Tonini GP; Gambini C; Mancini A; Tonegatti L; Carli M; di Montezemolo LC; Di Cataldo A; Casale F; Mazzocco K; Cecchetto G; Rizzo A; Bernardi B;
    Ann Oncol; 2002 Jun; 13(6):956-64. PubMed ID: 12123342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience of the Izmir Pediatric Oncology Group on Neuroblastoma: IPOG-NBL-92 Protocol.
    Olgun N; Kansoy S; Aksoylar S; Cetingul N; Vergin C; Oniz H; Sarialioglu F; Kantar M; Uysal K; Tuncyurek M; Kargi A; Aktas S; Bayol U; Karaca I; Arikan A; Balik E; Aktug T; Elmas N; Kovanlikaya A; Kinay M; Anacak Y; Degirmenci B; Burak Z
    Pediatr Hematol Oncol; 2003; 20(3):211-8. PubMed ID: 12637217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
    Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
    Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes.
    Avanzini S; Pio L; Erminio G; Granata C; Holmes K; Gambart M; Buffa P; Castel V; Valteau Couanet D; Garaventa A; Pistorio A; Cecchetto G; Martucciello G; Mattioli G; Sarnacki S
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28440012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete surgical resection combined with aggressive adjuvant chemotherapy and bone marrow transplantation prolongs survival in children with advanced neuroblastoma.
    Chamberlain RS; Quinones R; Dinndorf P; Movassaghi N; Goodstein M; Newman K
    Ann Surg Oncol; 1995 Mar; 2(2):93-100. PubMed ID: 7728576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma.
    Haase GM; O'Leary MC; Ramsay NK; Romansky SG; Stram DO; Seeger RC; Hammond GD
    J Pediatr Surg; 1991 Sep; 26(9):1119-23; discussion 1123-4. PubMed ID: 1941492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique.
    Rubie H; Plantaz D; Coze C; Michon J; Frappaz D; Baranzelli MC; Chastagner P; Peyroulet MC; Hartmann O;
    Med Pediatr Oncol; 2001 Jan; 36(1):247-50. PubMed ID: 11464897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
    Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC
    J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
    Strother DR; London WB; Schmidt ML; Brodeur GM; Shimada H; Thorner P; Collins MH; Tagge E; Adkins S; Reynolds CP; Murray K; Lavey RS; Matthay KK; Castleberry R; Maris JM; Cohn SL
    J Clin Oncol; 2012 May; 30(15):1842-8. PubMed ID: 22529259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroblastoma in the adult: the Italian experience with 21 patients.
    Sorrentino S; Gigliotti AR; Sementa AR; Morsellino V; Conte M; Erminio G; Buffa P; Granata C; Mazzocco K; Garaventa A; De Bernardi B
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):e499-505. PubMed ID: 24633299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group.
    Strother D; van Hoff J; Rao PV; Smith EI; Shamberger RC; Halperin EC; Murray KJ; Castleberry RP
    Eur J Cancer; 1997 Oct; 33(12):2121-5. PubMed ID: 9516866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J; Filippa DA; Qin J; Wollner N
    Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Can intensive induction chemotherapy eradicate retroperitoneal lymph node metastases in children over 1 year of age with stage 4 neuroblastoma?].
    Niezgoda A; Balwierz W; Bysiek A; Miezyński W; Klekawka T; Garus K
    Przegl Lek; 2004; 61 Suppl 2():9-13. PubMed ID: 15686039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
    George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT
    J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study.
    Adkins ES; Sawin R; Gerbing RB; London WB; Matthay KK; Haase GM
    J Pediatr Surg; 2004 Jun; 39(6):931-6. PubMed ID: 15185228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
    Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK
    J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infants with neuroblastoma and regional lymph node metastases have a favorable outlook after limited postoperative chemotherapy: a Pediatric Oncology Group study.
    Castleberry RP; Shuster JJ; Altshuler G; Smith EI; Nitschke R; Winick N; McWilliams N; Joshi V; Hayes FA
    J Clin Oncol; 1992 Aug; 10(8):1299-304. PubMed ID: 1634920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.